Literature DB >> 30023387

Policy and governance solutions for ensuring equitable access to cancer medicines in low- and middle-income countries.

Raphael E Cuomo1, Tim K Mackey1,2.   

Abstract

Entities:  

Year:  2018        PMID： 30023387      PMCID： PMC6035971          DOI： 10.21037/atm.2018.04.26

Source DB:  PubMed          Journal:  Ann Transl Med        ISSN： 2305-5839


× No keyword cloud information.
  10 in total

1.  Compulsory licensing often did not produce lower prices for antiretrovirals compared to international procurement.

Authors:  Reed F Beall; Randall Kuhn; Amir Attaran
Journal:  Health Aff (Millwood)       Date:  2015-03       Impact factor: 6.301

2.  Coordinating the UN System: lessons from UNAIDS: a commentary on Mackey.

Authors:  Devi Sridhar
Journal:  Soc Sci Med       Date:  2012-10-17       Impact factor: 4.634

Review 3.  The high price of anticancer drugs: origins, implications, barriers, solutions.

Authors:  Vinay Prasad; Kevin De Jesús; Sham Mailankody
Journal:  Nat Rev Clin Oncol       Date:  2017-03-14       Impact factor: 66.675

4.  ESMO International Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in countries outside of Europe.

Authors:  N I Cherny; R Sullivan; J Torode; M Saar; A Eniu
Journal:  Ann Oncol       Date:  2017-11-01       Impact factor: 32.976

5.  Patent and exclusivity status of essential medicines for non-communicable disease.

Authors:  Tim K Mackey; Bryan A Liang
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

6.  Essential medicines for cancer: WHO recommendations and national priorities.

Authors:  Jane Robertson; Ronald Barr; Lawrence N Shulman; Gilles B Forte; Nicola Magrini
Journal:  Bull World Health Organ       Date:  2016-07-05       Impact factor: 9.408

7.  Country and regional variations in purchase prices for essential cancer medications.

Authors:  Raphael E Cuomo; Robert L Seidman; Tim K Mackey
Journal:  BMC Cancer       Date:  2017-08-24       Impact factor: 4.430

Review 8.  Compulsory Licenses for Cancer Drugs: Does Circumventing Patent Rights Improve Access to Oncology Medications?

Authors:  Cinthia Leite Frizzera Borges Bognar; Brittany L Bychkovsky; Gilberto de Lima Lopes
Journal:  J Glob Oncol       Date:  2016-06-29

Review 9.  Proposing Essential Medicines to Treat Cancer: Methodologies, Processes, and Outcomes.

Authors:  Lawrence N Shulman; Claire M Wagner; Ronald Barr; Gilberto Lopes; Giuseppe Longo; Jane Robertson; Gilles Forte; Julie Torode; Nicola Magrini
Journal:  J Clin Oncol       Date:  2015-11-17       Impact factor: 44.544

Review 10.  Cancer prevention as part of precision medicine: 'plenty to be done'.

Authors:  Bernard W Stewart; Freddie Bray; David Forman; Hiroko Ohgaki; Kurt Straif; Andreas Ullrich; Christopher P Wild
Journal:  Carcinogenesis       Date:  2015-11-20       Impact factor: 4.944
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.